ReviewCancers2025

Treatment-Related Adverse Events in Individuals with BRAF-Mutant Cutaneous Melanoma Treated with BRAF and MEK Inhibitors: A Systematic Review and Meta-Analysis.

Silvia Belloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.